5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole

C116H113F11N18O17S — CID 157188241

IUPAC5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole
SMILESCc1cc(-c2ccc(OC3CC(F)(c4ccnc(CC5CCC5)c4)C3)nc2)on1.Cc1cc(-c2ccc(OC3CC(OCC4CCCCC4)C3)nc2)on1.Cc1cc(-c2cnc(OC3CC(OCc4ccc(F)cc4)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(Oc4cccc(OC(F)(F)F)c4)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(c4cccc(OC(F)F)c4F)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(c4nc(C(F)(F)F)cs4)C3)cn2)on1
InChIInChI=1S/C23H24FN3O2.C20H26N2O3.C19H16F3N3O4.C19H16F3N3O3.C19H18FN3O3.C16H13F3N4O2S/c1-15-9-21(29-27-15)17-5-6-22(26-14-17)28-20-12-23(24,13-20)18-7-8-25-19(11-18)10-16-3-2-4-16;1-14-9-19(25-22-14)16-7-8-20(21-12-16)24-18-10-17(11-18)23-13-15-5-3-2-4-6-15;1-11-5-17(29-25-11)16-9-24-18(10-23-16)27-15-7-14(8-15)26-12-3-2-4-13(6-12)28-19(20,21)22;1-10-5-16(28-25-10)14-8-24-17(9-23-14)26-12-6-11(7-12)13-3-2-4-15(18(13)20)27-19(21)22;1-12-6-18(26-23-12)17-9-22-19(10-21-17)25-16-7-15(8-16)24-11-13-2-4-14(20)5-3-13;1-8-2-12(25-23-8)11-5-21-14(6-20-11)24-10-3-9(4-10)15-22-13(7-26-15)16(17,18)19/h5-9,11,14,16,20H,2-4,10,12-13H2,1H3;7-9,12,15,17-18H,2-6,10-11,13H2,1H3;2-6,9-10,14-15H,7-8H2,1H3;2-5,8-9,11-12,19H,6-7H2,1H3;2-6,9-10,15-16H,7-8,11H2,1H3;2,5-7,9-10H,3-4H2,1H3
InChIKeyAPJNZDIZSSLHMP-UHFFFAOYSA-N
MW2272.33 g/mol
LogP26.52
Rot. Bonds34

About 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole

5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole (PubChem CID 157188241) has the molecular formula C116H113F11N18O17S and a molecular weight of 2272.33 g/mol. Its IUPAC name is 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole.

Molecular Properties

Compound Name5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole
PubChem CID157188241
Molecular FormulaC116H113F11N18O17S
Molecular Weight2272.33 g/mol
Exact Mass2270.81
IUPAC Name5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole
SMILESCc1cc(-c2ccc(OC3CC(F)(c4ccnc(CC5CCC5)c4)C3)nc2)on1.Cc1cc(-c2ccc(OC3CC(OCC4CCCCC4)C3)nc2)on1.Cc1cc(-c2cnc(OC3CC(OCc4ccc(F)cc4)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(Oc4cccc(OC(F)(F)F)c4)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(c4cccc(OC(F)F)c4F)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(c4nc(C(F)(F)F)cs4)C3)cn2)on1
InChIInChI=1S/C23H24FN3O2.C20H26N2O3.C19H16F3N3O4.C19H16F3N3O3.C19H18FN3O3.C16H13F3N4O2S/c1-15-9-21(29-27-15)17-5-6-22(26-14-17)28-20-12-23(24,13-20)18-7-8-25-19(11-18)10-16-3-2-4-16;1-14-9-19(25-22-14)16-7-8-20(21-12-16)24-18-10-17(11-18)23-13-15-5-3-2-4-6-15;1-11-5-17(29-25-11)16-9-24-18(10-23-16)27-15-7-14(8-15)26-12-3-2-4-13(6-12)28-19(20,21)22;1-10-5-16(28-25-10)14-8-24-17(9-23-14)26-12-6-11(7-12)13-3-2-4-15(18(13)20)27-19(21)22;1-12-6-18(26-23-12)17-9-22-19(10-21-17)25-16-7-15(8-16)24-11-13-2-4-14(20)5-3-13;1-8-2-12(25-23-8)11-5-21-14(6-20-11)24-10-3-9(4-10)15-22-13(7-26-15)16(17,18)19/h5-9,11,14,16,20H,2-4,10,12-13H2,1H3;7-9,12,15,17-18H,2-6,10-11,13H2,1H3;2-6,9-10,14-15H,7-8H2,1H3;2-5,8-9,11-12,19H,6-7H2,1H3;2-6,9-10,15-16H,7-8,11H2,1H3;2,5-7,9-10H,3-4H2,1H3
InChIKeyAPJNZDIZSSLHMP-UHFFFAOYSA-N
XLogP26.52
TPSA412.39 Ų
H-Bond Donors
H-Bond Acceptors36
Rotatable Bonds34
Heavy Atoms163
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002272.33
LogP ≤ 526.52
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1036

Analyze 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-[5-[3-(4-Cyclopropyloxyphenyl)cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[4-(difluoromethyl)-3-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[4-[3-(4-fluorophenyl)cyclobutyl]oxyphenyl]-3-methyl-1,2-oxazole;5-[6-[3-[3-fluoro-5-(trifluoromethyl)-2-pyridinyl]cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethoxy)phenyl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[5-(trifluoromethyl)-2-pyridinyl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole
CID 157104308

Frequently Asked Questions

What is the IUPAC name of 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole?
The IUPAC name of 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole (CID 157188241) is 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole.
What is the SMILES notation for 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole?
The canonical SMILES for 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole is Cc1cc(-c2ccc(OC3CC(F)(c4ccnc(CC5CCC5)c4)C3)nc2)on1.Cc1cc(-c2ccc(OC3CC(OCC4CCCCC4)C3)nc2)on1.Cc1cc(-c2cnc(OC3CC(OCc4ccc(F)cc4)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(Oc4cccc(OC(F)(F)F)c4)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(c4cccc(OC(F)F)c4F)C3)cn2)on1.Cc1cc(-c2cnc(OC3CC(c4nc(C(F)(F)F)cs4)C3)cn2)on1.
What is the InChIKey of 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole?
The InChIKey is APJNZDIZSSLHMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24FN3O2.C20H26N2O3.C19H16F3N3O4.C19H16F3N3O3.C19H18FN3O3.C16H13F3N4O2S/c1-15-9-21(29-27-15)17-5-6-22(26-14-17)28-20-12-23(24,13-20)18-7-8-25-19(11-18)10-16-3-2-4-16;1-14-9-19(25-22-14)16-7-8-20(21-12-16)24-18-10-17(11-18)23-13-15-5-3-2-4-6-15;1-11-5-17(29-25-11)16-9-24-18(10-23-16)27-15-7-14(8-15)26-12-3-2-4-13(6-12)28-19(20,21)22;1-10-5-16(28-25-10)14-8-24-17(9-23-14)26-12-6-11(7-12)13-3-2-4-15(18(13)20)27-19(21)22;1-12-6-18(26-23-12)17-9-22-19(10-21-17)25-16-7-15(8-16)24-11-13-2-4-14(20)5-3-13;1-8-2-12(25-23-8)11-5-21-14(6-20-11)24-10-3-9(4-10)15-22-13(7-26-15)16(17,18)19/h5-9,11,14,16,20H,2-4,10,12-13H2,1H3;7-9,12,15,17-18H,2-6,10-11,13H2,1H3;2-6,9-10,14-15H,7-8H2,1H3;2-5,8-9,11-12,19H,6-7H2,1H3;2-6,9-10,15-16H,7-8,11H2,1H3;2,5-7,9-10H,3-4H2,1H3.
What are the key properties of 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole?
5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole has a molecular weight of 2272.33 g/mol, XLogP of 26.52, 34 rotatable bonds, 0 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[6-[3-[2-(cyclobutylmethyl)-4-pyridinyl]-3-fluorocyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[6-[3-(cyclohexylmethoxy)cyclobutyl]oxy-3-pyridinyl]-3-methyl-1,2-oxazole;5-[5-[3-[3-(difluoromethoxy)-2-fluorophenyl]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;5-[5-[3-[(4-fluorophenyl)methoxy]cyclobutyl]oxypyrazin-2-yl]-3-methyl-1,2-oxazole;3-methyl-5-[5-[3-[3-(trifluoromethoxy)phenoxy]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole;3-methyl-5-[5-[3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]cyclobutyl]oxypyrazin-2-yl]-1,2-oxazole is sourced from PubChem (CID 157188241), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).